Asia
Europe, Middle East, Africa
North America
bioMérieux Corporate Website | Pioneering diagnostics
Tackling AMR together with the Fleming Fund
We are honored to have been selected as a supplier in a tender process by the Fleming Fund to tackle Antimicrobial Resistance (AMR) in low and middle-income countries, in Africa and Asia Pacific. This programme aims at improving access to diagnostics and curbing this public health threat.
In December 2019, an outbreak of pneumonia and acute respiratory infection occurred in the city of Wuhan, China.
Diagnostic tests make it possible to confirm or rule out whether the pathogen responsible for the infection is coronavirus COVID-19.